Cartesian Therapeutics (RNAC) Amortizatization of Intangibles (2016 - 2026)
Cartesian Therapeutics (RNAC) reported Amortizatization of Intangibles of $235000.0 for Q1 2026, up 27.72% year-over-year from $184000.0 in Q1 2025, and up 9.3% quarter-over-quarter from $215000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 10 years of Amortizatization of Intangibles data on file, last reported at $235000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $235000.0, up 27.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $829000.0 (down 60.69% YoY), and the FY2025 annual result was $778000.0, down 68.08% from the prior year.
- Amortizatization of Intangibles grew to $235000.0 in Q1 2026 per RNAC's latest filing, from $215000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.2 million in Q4 2022 and troughed at -$293000.0 in Q2 2022.
- A 5-year average of $408812.5 and a median of $264000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles tumbled 205.78% in 2022, then soared 836.72% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.2 million in 2022, then plunged by 60.63% to $476000.0 in 2023, then jumped by 40.97% to $671000.0 in 2024, then tumbled by 67.96% to $215000.0 in 2025, then rose by 9.3% to $235000.0 in 2026.
- Business Quant data shows RNAC's Amortizatization of Intangibles at $235000.0 in Q1 2026, $215000.0 in Q4 2025, and $192000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 235,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,000.00 |
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | 215,000.00 |
| Dec 31, 2025 | 215,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Jun 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 187,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Sep 30, 2024 | 653,000.00 |
| Sep 30, 2024 | 653,000.00 |
| Jun 30, 2024 | 601,000.00 |
| Jun 30, 2024 | 601,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Dec 31, 2023 | 476,000.00 |
| Dec 31, 2023 | 476,000.00 |